Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer
Clinical trial NCT00408603 · COMPLETED
Trial details
- NCT number
- NCT00408603
- Sponsor
- Sunesis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-20
- Primary completion
- 2010-06-09
- Enrollment
- 183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.